These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3072558)

  • 21. Pharmacokinetic and pharmacodynamic assessment of bioavailability for two prodrugs of methylprednisolone.
    Daley-Yates PT; Gregory AJ; Brooks CD
    Br J Clin Pharmacol; 1997 Jun; 43(6):593-601. PubMed ID: 9205819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-performance liquid chromatographic determination of hydrocortisone and methylprednisolone and their hemisuccinate esters in human serum.
    Smith MD
    J Chromatogr; 1979 Oct; 164(2):129-37. PubMed ID: 541404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-performance liquid chromatographic assay for methylprednisolone and its soluble prodrug esters in dog plasma.
    Shah JA; Weber DJ
    J Chromatogr; 1985 Nov; 344():41-9. PubMed ID: 3910669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of methylprednisolone acetate after intra-articular administration and subsequent suppression of endogenous hydrocortisone secretion in exercising horses.
    Menéndez MI; Phelps MA; Hothem EA; Bertone AL
    Am J Vet Res; 2012 Sep; 73(9):1453-61. PubMed ID: 22924728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The fate of soluble steroids within breast prostheses in humans.
    Morykwas MJ; Argenta LC; Oneal RM; Kaiser DG
    Ann Plast Surg; 1990 May; 24(5):427-30. PubMed ID: 2190525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical pharmacology of methylprednisolone sodium phosphate. I. Intramuscular route of administration.
    Novak E; DiSanto AR; Seckman CE; Elliott G; Lee JG; Stubbs SS
    J Clin Pharmacol; 1977; 17(5-6):324-33. PubMed ID: 323297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylprednisolone hemisuccinate and metabolites in urine from patients receiving high-dose corticosteroid therapy.
    Lawson GJ; Chakraborty J; Dumasia MC; Baylis EM
    Ther Drug Monit; 1992 Feb; 14(1):20-6. PubMed ID: 1546386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylprednisolone concentrations in the vitreous and the serum after pulse therapy.
    Behar-Cohen FF; Gauthier S; El Aouni A; Chapon P; Parel JM; Renard G; Chauvaud D
    Retina; 2001; 21(1):48-53. PubMed ID: 11217929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of methylprednisolone in cat plasma and spinal cord following a single intravenous dose of the sodium succinate ester.
    Braughler JM; Hall ED
    Drug Metab Dispos; 1982; 10(5):551-2. PubMed ID: 6128209
    [No Abstract]   [Full Text] [Related]  

  • 30. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: plasma and tissue disposition.
    Zhang X; Mehvar R
    J Pharm Sci; 2001 Dec; 90(12):2078-87. PubMed ID: 11745766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-performance liquid chromatography analysis, preliminary pharmacokinetics, metabolism and renal excretion of methylprednisolone with its C6 and C20 hydroxy metabolites in multiple sclerosis patients receiving high-dose pulse therapy.
    Vree TB; Lagerwerf AJ; Verwey-van Wissen CP; Jongen PJ
    J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(2):337-48. PubMed ID: 10517356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disposition of methylprednisolone and its sodium succinate prodrug in vivo and in perfused liver of rats: nonlinear and sequential first-pass elimination.
    Kong AN; Jusko WJ
    J Pharm Sci; 1991 May; 80(5):409-15. PubMed ID: 1880717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of prednisolone after high doses of prednisolone hemisuccinate.
    Derendorf H; Rohdewald P; Möllmann H; Rehder J; Barth J; Neveling D
    Biopharm Drug Dispos; 1985; 6(4):423-32. PubMed ID: 4084667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrolysis of methylprednisolone hemisuccinate to methylprednisolone by a nonspecific carboxylesterase.
    Oshima T; Nakajima E; Hattori K
    Pharmacol Res Commun; 1980 Feb; 12(2):139-46. PubMed ID: 6992149
    [No Abstract]   [Full Text] [Related]  

  • 35. Placental transfer of methylprednisolone following maternal intravenous administration.
    Anderson GG; Rotchell Y; Kaiser DG
    Am J Obstet Gynecol; 1981 Jul; 140(6):699-701. PubMed ID: 7020419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-performance size-exclusion chromatographic analysis of dextran-methylprednisolone hemisuccinate in rat plasma.
    Mehvar R
    J Chromatogr B Biomed Sci Appl; 2000 Jul; 744(2):293-8. PubMed ID: 10993517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of corticosteroids on eosinophil chemotaxis and adherence.
    Altman LC; Hill JS; Hairfield WM; Mullarkey MF
    J Clin Invest; 1981 Jan; 67(1):28-36. PubMed ID: 7005265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis.
    Morrow SA; Stoian CA; Dmitrovic J; Chan SC; Metz LM
    Neurology; 2004 Sep; 63(6):1079-80. PubMed ID: 15452302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High dose intravenous methylprednisolone "pulse" therapy in patients with rheumatoid disease. Plasma methylprednisolone levels and adrenal function.
    Baylis EM; Williams IA; English J; Marks V; Chakraborty J
    Eur J Clin Pharmacol; 1982; 21(5):385-8. PubMed ID: 7042371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous infusion of methylprednisolone via paediatric parenteral nutrition: a pharmacokinetic animal study.
    Gellis C; Sautou-Miranda V; Bleyzac N; Jarrige JF; Minet-Quinard R; Chopineau J
    Clin Nutr; 2007 Aug; 26(4):491-7. PubMed ID: 17442463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.